Avella of Deer Valley, Inc. Store 38 recalls Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE
Avella recalls specific bevacizumab prefilled syringes due to lack of sterility assurance. This may pose infection risks. Affected units have lot number 138-20191202@64 and expire 05/13/19.
Recall notice
Lack of assurance of sterility
Contact the company & request your remedy
What happened, in plain English
Avella is recalling certain bevacizumab prefilled syringes because they lack sterility assurance. This could lead to infections if the medication is used. The affected products have a specific lot number and expiration date. Read more at govinfonow.com/recall/38844-avella-bevacizumab-prefilled-syringes-recall-lack-of-sterility-assurance.
Source Summary by GovInfoNow · govinfonow.com/recall/38844-avella-bevacizumab-prefilled-syringes-recall-lack-of-sterility-assurance · Updated October 5, 2026 · FDA enforcement record: FDA #D-1308-2019
Cite this page
“Avella Bevacizumab Prefilled Syringes Recall: Lack of Sterility Assurance.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38844-avella-bevacizumab-prefilled-syringes-recall-lack-of-sterility-assurance. Based on FDA recall #D-1308-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1308-2019%22&limit=1).
Why it’s dangerous
The syringes were not properly sterilized, which could allow bacteria to enter the medication. This poses a risk of infection when the medication is administered to patients. The lack of sterility assurance means the product may not be safe for use.
Who’s affected
Patients prescribed bevacizumab by a doctor who received this specific syringe product are affected. Those using the recalled syringes for cancer treatment may be at risk of infection.
How to tell if you have this one
Check for the lot number 138-20191202@64 on the syringe packaging. The product expires May 13, 2019. This recall applies to bevacizumab 2.5 mg/0.1 mL prefilled syringes.
- Brand
Avella- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 138-20191202@64 and expiration date of May 13, 2019 on the syringe packaging.
Questions people ask
Is this product safe to use?
No, the product has a lack of sterility assurance and may cause infections. Do not use this product.
How do I know if I have the recalled product?
Check for the lot number 138-20191202@64 and expiration date of May 13, 2019 on the syringe packaging.
What should I do if I have the recalled product?
Do not use the product. Contact your doctor or the manufacturer for further instructions.
Contact Avella
We’ve drafted a message you can send Avella to request your refund or repair — edit it as you like.
Subject: Recall D-1308-2019 — Avella Avella Hello, I own a Avella that is covered by recall D-1308-2019 from Avella. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1308-2019 (May 3, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1308-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
